Investors Buy Shares of Aurora Cannabis (ACB) on Weakness

Share on StockTwits

Traders purchased shares of Aurora Cannabis Inc (NYSE:ACB) on weakness during trading hours on Thursday. $131.48 million flowed into the stock on the tick-up and $92.16 million flowed out of the stock on the tick-down, for a money net flow of $39.32 million into the stock. Of all companies tracked, Aurora Cannabis had the 22nd highest net in-flow for the day. Aurora Cannabis traded down ($0.08) for the day and closed at $8.99

A number of brokerages have recently weighed in on ACB. GMP Securities upgraded Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Wednesday. Cowen began coverage on Aurora Cannabis in a research report on Tuesday, March 5th. They issued an “outperform” rating for the company. TheStreet cut Aurora Cannabis from a “c” rating to a “d+” rating in a research report on Monday, February 25th. Jefferies Financial Group assumed coverage on Aurora Cannabis in a research report on Monday, February 25th. They issued a “buy” rating for the company. Finally, Seaport Global Securities assumed coverage on Aurora Cannabis in a research note on Thursday, February 21st. They set a “neutral” rating on the stock. One analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $9.50.

The company has a debt-to-equity ratio of 0.08, a current ratio of 3.31 and a quick ratio of 2.50. The company has a market cap of $8.06 billion, a P/E ratio of 74.92 and a beta of 2.90.

Aurora Cannabis (NYSE:ACB) last posted its quarterly earnings data on Monday, February 11th. The company reported ($0.04) EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $41.00 million for the quarter. Aurora Cannabis had a positive return on equity of 3.95% and a negative net margin of 57.54%. Research analysts predict that Aurora Cannabis Inc will post -0.17 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Financial Advocates Investment Management acquired a new stake in shares of Aurora Cannabis during the fourth quarter valued at $74,000. Flagship Harbor Advisors LLC acquired a new stake in shares of Aurora Cannabis during the fourth quarter valued at $26,000. Advisory Services Network LLC acquired a new stake in shares of Aurora Cannabis during the fourth quarter valued at $29,000. Trustcore Financial Services LLC acquired a new stake in shares of Aurora Cannabis during the fourth quarter valued at $33,000. Finally, Farmers & Merchants Trust Co of Chambersburg PA acquired a new stake in shares of Aurora Cannabis during the fourth quarter valued at $36,000. 8.16% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: “Investors Buy Shares of Aurora Cannabis (ACB) on Weakness” was first published by Week Herald and is owned by of Week Herald. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://weekherald.com/2019/03/14/investors-buy-shares-of-aurora-cannabis-acb-on-weakness.html.

Aurora Cannabis Company Profile (NYSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: Should I invest in “strong buy” stocks?

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply